INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-434 Cr | ₹-208 Cr | ₹-121 Cr | ₹-67 Cr | ₹-56 Cr |
What is the latest Cash Flow from Investing Activities ratio of INDOCO REMEDIES ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-434 Cr |
Mar2023 | ₹-208 Cr |
Mar2022 | ₹-121 Cr |
Mar2021 | ₹-67 Cr |
Mar2020 | ₹-56 Cr |
How is Cash Flow from Investing Activities of INDOCO REMEDIES Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-434 Cr | Negative | |
Mar2023 | ₹-208 Cr | Negative | |
Mar2022 | ₹-121 Cr | Negative | |
Mar2021 | ₹-67 Cr | Negative | |
Mar2020 | ₹-56 Cr | - |
Compare Cash Flow from Investing Activities of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,760.0 Cr | -7.6% | -9.1% | -7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -7.6% |
-9.1% |
-7% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses